(Q54255722)

26 May 2018

review article

1 reference

reason for deprecated rank

title

For which hypertensive patient should angiotensin-converting enzyme inhibitor be prescribed or forbidden? (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1299938

10 September 2022

author name string

B. Chamontin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1299938

10 September 2022

J. Amar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1299938

10 September 2022

F. Begasse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1299938

10 September 2022

M. Salvador

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1299938

10 September 2022

language of work or name

French

0 references

publication date

1 December 1992

1 reference

26 May 2018

15 December 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1299938

10 September 2022

published in

La Revue du praticien

1 reference

26 May 2018

volume

42

1 reference

26 May 2018

issue

20

1 reference

26 May 2018

page(s)

2545-2549

1 reference

26 May 2018

Identifiers

1 reference

26 May 2018